XML 62 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock Options and Stock Appreciation Rights (Tables)
12 Months Ended
Dec. 31, 2023
Stock Options and Stock Appreciation Rights  
Schedule of Black-Scholes-Merton option valuation model assumptions

    

2022

 

Expected Life (Years)

 

7.00

Dividend yield

 

3.08

%

Interest rate

 

1.94

%

Volatility

 

37.78

%

Summary of option activity under stock option plans

    

    

    

Weighted

    

    

Weighted

average

average

remaining

Aggregate

Number of

exercise

contractual

intrinsic

options

price

term (years)

value ($)

(in Thousands)

Options outstanding at December 31, 2022

 

461,822

$

29.67

Plus: Options granted

 

 

Less:

Options exercised

 

(46,444)

 

25.12

Options expired

 

 

Options forfeited

 

(31,513)

 

24.52

Options outstanding at December 31, 2023

 

383,865

 

30.65

 

3.42

$

9,088

Options fully vested and exercisable at December 31, 2023

 

232,143

$

27.80

 

1.96

$

6,157

Summary of activity under the SAR Plan

    

    

    

Weighted

    

    

Weighted

average

Number of

average

remaining

Aggregate

stock appreciation

exercise

contractual

intrinsic

rights

price

term (years)

value ($)

(in Thousands)

Stock appreciation rights outstanding at December 31, 2022

 

489,250

$

39.35

Plus: Stock appreciation rights granted

 

Less:

Stock appreciation rights exercised

 

Stock appreciation rights expired

 

Stock appreciation rights forfeited

 

(24,000)

39.33

Stock appreciation rights outstanding at December 31, 2023

 

465,250

 

39.35

 

8.50

6,964

Stock appreciation rights fully vested and exercisable at December 31, 2023

 

$

 

Schedule of other information pertaining to option activity

Twelve Months Ended December 31,

 

2023

2022

2021

 

Weighted average grant date fair value of stock options granted

    

$

    

$

11.24

    

$

10.20

Total fair value of stock options vested

$

514,000

$

514,000

$

1,308,000

Total intrinsic value of stock options exercised

$

1,060,000

$

1,670,000

$

2,536,000